TY  - JOUR
AU  - Vincenzi, Bruno
AU  - Napolitano, Andrea
AU  - Fiocco, Marta
AU  - Mir, Olivier
AU  - Rutkowski, Piotr
AU  - Jean-Yves, Blay
AU  - Reichardt, Peter
AU  - Joensuu, Heikki
AU  - Fumagalli, Elena
AU  - Gennatas, Spyridon
AU  - Hindi, Nadia
AU  - Nannini, Margherita
AU  - Spalato-Ceruso, Mariella
AU  - Italiano, Antoine
AU  - Grignani, Giovanni
AU  - Brunello, Antonella
AU  - Gasperoni, Silvia
AU  - De-Pas, Tommaso
AU  - Badalamenti, Giuseppe
AU  - Pantaleo, Maria A
AU  - van-Houdt, Winan J
AU  - IJzerman, Nikki S
AU  - Steeghs, Neeltje
AU  - Gelderblom, Hans
AU  - Desar, Ingrid M E
AU  - Falkenhorst, Johanna
AU  - Silletta, Marianna
AU  - Sbaraglia, Marta
AU  - Tonini, Giuseppe
AU  - Martin-Broto, Javier
AU  - Hohenberger, Peter
AU  - Le-Cesne, Axel
AU  - Jones, Robin L
AU  - Dei-Tos, Angelo P
AU  - Gronchi, Alessandro
AU  - Bauer, Sebastian
AU  - Casali, Paolo G
PY  - 2021
DO  - 10.1158/1078-0432.CCR-21-1665
UR  - http://hdl.handle.net/10668/20185
T2  - Clinical cancer research : an official journal of the American Association for Cancer Research
AB  - The effect of high-dose imatinib (800 mg/day) on survival in the adjuvant treatment of patients with resected KIT exon 9-mutated gastrointestinal stromal tumors (GIST) is not established. Here, the association of dose and other clinicopathologic...
LA  - en
PB  - American Association for Cancer Research
KW  - Adjuvants, Immunologic
KW  - Chemotherapy, Adjuvant
KW  - Gastrointestinal Stromal Tumors
KW  - Imatinib Mesylate
KW  - Neoplasm Recurrence, Local
KW  - Retrospective Studies
KW  - Antineoplastic Agents
KW  - Exons
KW  - Humans
KW  - Mutation
KW  - Proto-Oncogene Proteins c-kit
TI  - Adjuvant Imatinib in Patients with GIST Harboring Exon 9 KIT Mutations: Results from a Multi-institutional European Retrospective Study.
TY  - research article
VL  - 28
ER  -